Compound Detail
CHEMBL92484
APTIGANEL 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL92484 |
| Name | APTIGANEL |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | BFNCJMURTMZBTE-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
4
Publications
1
Known Names
Molecular Properties
303.4
MW (Da)
4.89
ALogP
1
HBA
2
HBD
39.1
PSA (Ų)
0.53
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Activity Summary
IC50 2 meas. best 7.44
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Glutamate NMDA receptor CHEMBL1907608 | IC50 | 7.44 | 7.44 | 36.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | IC50 | 5.59 | 5.59 | 2540.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Glutamate NMDA receptor | IC50 | = | 36.0 | nM | 7.44 | In vitro concentration required to inhibit specific [3H]MK-801 radioligand bindi... | 8295213 |
| Sigma non-opioid intracellular receptor 1 | IC50 | = | 2540.0 | nM | 5.59 | Tested in vitro for the concentration required to inhibit specific [3H]DTG radio... | 8295213 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 8295213 | 10.1021/jm00028a009 | Glutamate NMDA receptor | 1 |
| 8295213 | 10.1021/jm00028a009 | Sigma non-opioid intracellular receptor 1 | 1 |
| - | 10.6019/CHEMBL3301361 | No relevant target | 1 |
Data from ChEMBL 36 via Core Engine